ARS Pharmaceuticals Statistics

Total Valuation

SPRY has a market cap or net worth of $1.09 billion. The enterprise value is $881.82 million.

Market Cap	1.09B
Enterprise Value	881.82M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

SPRY has 97.19 million shares outstanding. The number of shares has increased by 9.54% in one year.

Current Share Class	97.19M
Shares Outstanding	97.19M
Shares Change (YoY)	+9.54%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	19.70%
Owned by Institutions (%)	36.31%
Float	45.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	13.05
PB Ratio	5.40
P/TBV Ratio	5.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	343.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.56, with a Debt / Equity ratio of 0.00.

Current Ratio	12.56
Quick Ratio	12.40
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -22.41% and return on invested capital (ROIC) is -17.24%.

Return on Equity (ROE)	-22.41%
Return on Assets (ROA)	-16.22%
Return on Capital (ROIC)	-17.24%
Revenue Per Employee	$98,769
Profits Per Employee	-$1.89M
Employee Count	26
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +113.36% in the last 52 weeks. The beta is 0.86, so SPRY's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	+113.36%
50-Day Moving Average	14.37
200-Day Moving Average	11.43
Relative Strength Index (RSI)	32.88
Average Volume (20 Days)	1,121,791

Short Selling Information

The latest short interest is 13.63 million, so 14.02% of the outstanding shares have been sold short.

Short Interest	13.63M
Short Previous Month	13.85M
Short % of Shares Out	14.02%
Short % of Float	29.64%
Short Ratio (days to cover)	11.02

Income Statement

In the last 12 months, SPRY had revenue of $2.57 million and -$49.10 million in losses. Loss per share was -$0.51.

Revenue	2.57M
Gross Profit	-17.30M
Operating Income	-60.51M
Pretax Income	-44.84M
Net Income	-49.10M
EBITDA	-60.44M
EBIT	-60.51M
Loss Per Share	-$0.51

Full Income Statement

Balance Sheet

The company has $204.82 million in cash and $102,000 in debt, giving a net cash position of $204.71 million or $2.11 per share.

Cash & Cash Equivalents	204.82M
Total Debt	102,000
Net Cash	204.71M
Net Cash Per Share	$2.11
Equity (Book Value)	200.98M
Book Value Per Share	2.07
Working Capital	192.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$45.86 million and capital expenditures -$170,000, giving a free cash flow of -$46.03 million.

Operating Cash Flow	-45.86M
Capital Expenditures	-170,000
Free Cash Flow	-46.03M
FCF Per Share	-$0.47

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,356.15%
Pretax Margin	-1,912.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SPRY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.54%
Shareholder Yield	-9.54%
Earnings Yield	-4.52%
FCF Yield	-4.24%

Analyst Forecast

The average price target for SPRY is $24.00, which is 114.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$24.00
Price Target Difference	114.67%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	425.18%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SPRY has an Altman Z-Score of 27.52 and a Piotroski F-Score of 3.

Altman Z-Score	27.52
Piotroski F-Score	3